Tag: Cancer
-
New Role for Dopamine in Deadly Brain Cancer
A Northwestern Medicine study has demonstrated the role of dopamine in the progression of glioblastoma and suggests that targeting the neurotransmitter may slow cancer growth.
-
Yanez Honored for Work in Psychosocial Oncology
Betina Yanez, PhD, received the New Investigator Award 2019 from the American Psychosocial Oncology Society.
-
Gene Transcription Factor Controls Fat Tissue Expansion
Subcutaneous fat cells in mice expanded after a gene transcription factor was deleted, according to a new study published in Cell Reports.
-
Study Suggests New Strategy to Treat Advanced Prostate Cancer
A Northwestern Medicine study provides new insights into a signaling pathway in metastatic prostate cancer and suggests that a novel drug combination may improve treatment response and slow cancer growth.
-
Scientists Create Uterine Stem Cells for the First Time
Northwestern scientists have successfully transformed induced pluripotent stem cells into endometrial cells, which line the uterus and are involved in several uterine conditions such as endometrial cancer and infertility.
-
How Neutrophils Drive DNA Damage Linked to Cancer
Northwestern Medicine scientists demonstrated how innate immune cells in inflamed tissue induce DNA damage that promotes the development of cancer.
-
Full-Body Scan Could Improve Chemotherapy Effectiveness
A new full-body scan could help clinicians better assess patients during cancer treatment, according to a recent study.
-
New Gene Associated With Glioblastoma Discovered
Northwestern Medicine scientists have identified a gene, called isocitrate dehydrogenase 3-alpha, that promotes tumors in grade IV glioblastoma, according to a study published in Science Advances.
-
Pediatric Leukemia ‘Super Drug’ Could be Developed in Coming Years
Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, the first step towards a pediatric leukemia “super drug.”
-
Drug Regimen Improves Survival in Lymphoma
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
